Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This phase 3, multi-center, double blind, placebo-controlled, randomized clinical trial will
attempt to demonstrate if preterm infants who require mechanical ventilation and/or positive
pressure support at any point during days 5 to 14 after birth may benefit from treatment with
iNO.